
PF-9184
CAS No. 1221971-47-6
PF-9184 ( PF9184 )
产品货号. M10842 CAS No. 1221971-47-6
PF-9184 是一种有效的选择性 mPGES-1(微粒体前列腺素 E 合酶-1)抑制剂,IC50 为 16.5 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥940 | 有现货 |
![]() ![]() |
10MG | ¥1418 | 有现货 |
![]() ![]() |
25MG | ¥2414 | 有现货 |
![]() ![]() |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PF-9184
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PF-9184 是一种有效的选择性 mPGES-1(微粒体前列腺素 E 合酶-1)抑制剂,IC50 为 16.5 nM。
-
产品描述PF-9184 is a potent, selective mPGES-1 (microsomal prostaglandin E synthase-1) inhibitor with IC50 of 16.5 nM; shows no effect against COX-1 and COX-2 (>6,500-fold selectivity); inhibits PGE2 synthesis in serum-free cell and human whole blood cultures with IC50 of 0.5-5 uM, while sparing the synthesis of PGF(1alpha)) and PGF(2alpha).
-
体外实验PF-9184 (0.015-100 μM; 24 hours) inhibits IL-1β-stimulated prostaglandin E2 (PGE2) synthesis in rheumatoid arthritis (RASF) in synovial fibroblasts derived from patients and has no apparent cytotoxic effects up to 100 μM.PF-9184 (0.015-100 μM) potently blocks mPGES-1 ability to synthesize PGE2 from PGH2, and with no apparent inhibitory effects on COX-2 and prostacyclin synthase in cells.PF-9184 (0.015-100 μM) inhibits PGE2 weakly but has no effect on TXB2 synthesis except at 100 μM in human whole blood and modified blood assays.PF-9184 is a poor inhibitor of recombinant rat mPGES-1 (IC50=1080±398 nM).
-
体内实验PF-9184 (oral administration or even local delivery) has no effect on PGE2 synthesis in recombinant rats.
-
同义词PF9184
-
通路Immunology/Inflammation
-
靶点PGE synthase
-
受体PGE synthase
-
研究领域——
-
适应症——
化学信息
-
CAS Number1221971-47-6
-
分子量461.3
-
分子式C21H14Cl2N2O4S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(C1=C(O)C2=CC=CC=C2S(N1)(=O)=O)NC3=CC=C(C4=CC=C(Cl)C(Cl)=C4)C=C3
-
化学全称2H-1,2-Benzothiazine-3-carboxamide, N-(3',4'-dichloro[1,1'-biphenyl]-4-yl)-4-hydroxy-,1,1-dioxide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Mbalaviele G, et al. Biochem Pharmacol. 2010 May 15;79(10):1445-54.
2. Chang HH, et al. Future Med Chem. 2011 Nov;3(15):1909-34.
产品手册




关联产品
-
PF-9184
PF-9184 是一种有效的选择性 mPGES-1(微粒体前列腺素 E 合酶-1)抑制剂,IC50 为 16.5 nM。
-
LY3031207
一种新型强效 (IC50=910 ng/mL)、高选择性微粒体前列腺素 E 合酶 1 抑制剂 (mPGES-1),用于治疗未公开的适应症。
-
Crisdesalazine
Crisdesalazine (AAD-2004、AAD2004) 是阿司匹林的衍生物,可抑制微粒体 PGE(2) 合酶-1 (mPGES-1) 活性,以响应 LPS 处理的 BV2 细胞(IC50 为 230 nM)和重组人 mPGES-1 蛋白体外 IC50 为 249 nM。